The Disparity Between Funding for Eye Research Vs. the High Cost of Sight-loss in the UK
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Liu W, Taylor L, MacLaren R, Jolly J Clin Ophthalmol. 2023; 17:2729-2735.
PMID: 37743890 PMC: 10516213. DOI: 10.2147/OPTH.S417773.
Advances in machine learning to detect preventable causes of blindness.
Waisberg E, Ong J, Paladugu P, Kamran S, Zaman N, Tavakkoli A Eye (Lond). 2022; 37(12):2582-2583.
PMID: 36496462 PMC: 10397272. DOI: 10.1038/s41433-022-02354-2.
References
1.
Shalaby A, Lewis K, Bush K, Meredith P, Di Simplicio S, Lockwood A
. Licence to save: a UK survey of anti-VEGF use for the eye in 2015. Eye (Lond). 2016; 30(11):1404-1406.
PMC: 5108014.
DOI: 10.1038/eye.2016.154.
View
2.
Liew G, Michaelides M, Bunce C
. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014; 4(2):e004015.
PMC: 3927710.
DOI: 10.1136/bmjopen-2013-004015.
View
3.
Christensen D, Brown F, Cree A, Ratnayaka J, Lotery A
. Sorsby fundus dystrophy - A review of pathology and disease mechanisms. Exp Eye Res. 2017; 165:35-46.
DOI: 10.1016/j.exer.2017.08.014.
View
4.
North V, Gelman R, Tsang S
. Juvenile-onset macular degeneration and allied disorders. Dev Ophthalmol. 2014; 53:44-52.
PMC: 4405533.
DOI: 10.1159/000357293.
View
5.
Owen C, Jarrar Z, Wormald R, Cook D, Fletcher A, Rudnicka A
. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012; 96(5):752-6.
PMC: 3329633.
DOI: 10.1136/bjophthalmol-2011-301109.
View